Gene | Abbreviation | Accession number | Cytoband | References |
---|---|---|---|---|
A disintegrin and metalloproteinase domain 12 (meltrin alpha) | ADAM12 | NP_067673 | 10q26.3 | [45] |
Actin alpha 1, alpha smooth muscle antigen | ACTA1/ASMA | NP_001091 | 1q42.13-q42.2 | [45] |
Apolipoprotein E | APOE | NP_000032 | 19q13.2 | [45] |
ATP-binding cassette, subfamily A, member 1 | ABCA1 | NP_005493 | 9q31.1 | [45] |
ATP-binding cassette, subfamily G, member 2 | ABCG2/BCRP | NP_004818 | 4q22 | [42,43] |
Catenin (cadherin-associated protein), alpha 1 (102 kDa) | CTNNA1 | NP_001894 | 5q31 | [39] |
CD44 antigen | CD44 | NP_001001392 | 11p13 | [38] |
Chemokine (C–C motif) ligand 2 | CCL2 | NP_002973 | 17q11.2-q21.1 | [45] |
Cyclin D2 | CCND2 | NP_001750 | 12p13 | [45] |
Cyclin-dependent kinase inhibitor 1A (p21, Cip1) | CDKN1A | NP_510867 | 6p21.2 | [49,50] |
Decorin | DCN | NP_598014 | 12q13.2 | [45] |
Epithelial membrane protein 3 | EMP3 | NP_001416 | 19q13.3 | [45] |
Estrogen receptor 1 | ESR1 | NP_000116 | 6q25.1 | [47, 49-51] |
Fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome) | FGFR1 | NP_075599 | 8p11.2-p11.1 | [45] |
Flotillin 2 (epithelial-specific antigen) | FLOT2/ESA | NP_004466 | 17q11-q12 | [36,37,44,51] |
Four and a half LIM domains 1 | FHL1 | NP_001440 | Xq26 | [45] |
Frizzled homolog 2 (Drosophila) | FZD2 | NP_001457 | 17q21.1 | [45] |
FYN oncogene related to SRC, FGR, YES | FYN | NP_694593 | 6q21 | [45] |
Glycoprotein (transmembrane) nmb | GPNMB | NP_002501 | 7p15 | [45] |
Glypican 4 | GPC4 | NP_001439 | Xq26.1 | [45] |
Growth-associated protein 43 | GAP43 | NP_002036 | 3q13.1-q13.2 | [45] |
Growth hormone receptor | GHR | NP_000154 | 5p13-p12 | [45] |
Insulin-like growth factor 2 receptor | IGF2R | NP_000867 | 6q26 | [45] |
Insulin-like growth factor binding protein 4 | IGFBP4 | NP_001543 | 17q12-q21.1 | [45] |
Insulin-like growth factor binding protein 7 | IGFPP7 | NP_001544 | 4q12 | [45] |
Integrin, alpha 6 | ITGA6 | NP_000201 | 2q31.1 | [36,37,45] |
Keratin 19 | KRT19 | NP_002267 | 17q21.2 | [48-50] |
Lymphocyte antige 6 complex, sca-1 | LY6A/SCA-1 | NP_034868 | 15 | [40,41,43] |
Membrane metallo-endopeptidase (neutral endopeptidase, enkephalinase, CALLA, CD10) | MME/CALLA/CD10 | NP_009220 | 3q25.1-q25.2 | [36,37,45,49,51] |
Mucin 1 (transmembrane), epithelial membrane antigen | MUC1/EMA | NP_877418 | 1q21 | [36,37, 43-45, 49,51] |
Musashi homolog 1 (Drosophila) | MSI1 | NP_002433 | 12q24.1-q24.31 | [49,50] |
Nidogen (enactin) | NID | NP_002499 | 1q43 | [45] |
Notch homolog 1, translocation-associated (Drosophila) | NOTCH1 | NP_060087 | 9q34.3 | [49] |
Notch homolog 3 (Drosophila) | NOTCH3 | NP_000426 | 19p13.2-p13.1 | [45] |
Notch homolog 4 (Drosophila) | NOTCH4 | NP_004548 | 6p21.3 | [49] |
P53 target zinc finger protein | WIG1 | NP_689426 | 3q26.3-q27 | [45] |
Periostin, osteoblast specific factor | POSTN | NP_006466 | 13q13.3 | [45] |
Platelet-derived growth factor receptor, beta polypeptide | PDGFRB | NP_002600 | 5q31-q32 | [45] |
Polycystic kidney disease 2 (autosomal dominant) | PKD2 | NP_000288 | 4q21-q23 | [45] |
Progesterone receptor | PGR | NP_000917 | 11q22-q23 | [41,47,49,50] |
Prostate tumor overexpressed gene 1 | PTOV1 | NP_059128 | 19q13.33 | [45] |
Retinoic acid receptor responder (tazarotene induced) 3 | RARRES3 | NP_004576 | 11q23 | [45] |
Stem cell growth factor; lymphocyte secreted C-type lectin | SCGF | NP_002966 | 19q13.3 | [45] |
Telomerase reverse transcriptase | TERT | NP_937986 | 5p15.33 | [43] |
Tenascin C (hexabrachion) | TNC | NP_002151 | 9q33 | [45] |
Tight junction protein 1 (zona occludens 1) | TJP1 | NP_783297 | 15q13 | [39] |
Tissue inhibitor of metalloproteinase 3 | TIMP3 | NP_000353 | 22q12.1-q13.2 | [45] |
Wiskott–Aldrich syndrome protein interacting protein | WASPIP | NP_003378 | 2q31.1 | [45] |